Wednesday September 29, 1999


ABORTED BABY PARTS RESEARCH AND PATIENT ABUSE

Holes Drilled Into Patients Head For Fake Treatment

This week the New England Journal of Medicine discusses the ethics involved in testing an experimental treatment for Parkinson's disease involving the injection of brain tissue from aborted babies into the brains of Parkinson's patients. The research has been plagued with the ethical nightmare around the use of aborted baby parts and is now embroiled in the controversy over its handling of "control group" subjects in its experiments. Control group subjects - those not actually given the treatment are led to believe they are being treated in order to test for placebo effects. They have holes drilled in their heads just like experimental subjects but are not given the supposedly beneficial injection of baby brains.

Canada has been engaged in such research for many years and is one of 18 centres around the world performing such operations. According to authorities in the field, Canada is leading the way in these experiments, primarily at the lab of Dr. Ivar Mendez at Dalhousie University in Halifax. Alberta Report magazine noted last month that Dr. Mendez, received a $90,042 grant from the Medical Research Council of Canada for 1999-2000.

The Independent reports that the Helsinki declaration on research requires that the interests of science and society should never take precedence over the individual.

See the story in the NEJM at:
http://www.nejm.org/content/1999/0341/0013/0992.asp

See The Independent at:
http://www.independent.co.uk/atp/INDEPENDENT/NEWS/P5S4.html

URL: http://www.lifesitenews.com/ldn/1999/sep/99092901.html


Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.